CASE STUDY | CONSULTING
When Market Opportunity Was Unclear, We Defined Where the Product Would Win.
THE CHALLENGE
Determining Where a Novel Dermatology Therapy Would Win in the Market
A pharmaceutical company developing a new dermatology therapy with a novel mechanism of action needed to evaluate its market potential as it progressed from Phase II to Phase III clinical development.
To move forward with confidence, the organization needed to understand the treatment landscape, identify the most attractive patient segments, and assess how the evolving product profile aligned with patient and customer needs.
THE BREAKTHROUGH
Building a Data-Driven Pharmaceutical Product Strategy to Guide Clinical Investment
BGBx Strategic Advisors identified that defining the right product strategy required more than market sizing. It required a structured, evidence-based understanding of current care practices, unmet needs, and how the product profile aligned with patient and customer needs.
The approach included:
- Physician and patient qualitative interviews to assess current care practices, unmet needs, and interest in adoption
- Quantitative physician and patient surveys, including conjoint and pricing analysis
- Demand modeling to test launch assumptions, adoption, share capture, and segmentation
- A detailed 10-year forecast model with upside and downside scenarios
- A strategic business case to refine commercialization strategy and support clinical investment decisions
This approach provided a clear, data-driven view of market dynamics, product profile alignment, and future opportunity.
THE RESULTS
Validated Market Opportunity and Strengthened Product and Investment Strategy
The analysis enabled the organization to better understand market dynamics, identify opportunities to improve the product profile, and validate overall market potential.
These insights informed prioritization of future clinical development and strengthened decision-making around where to focus investment to support continued advancement of the product.
10-Year
Forecast Model
Built with scenarios
Phase II–III
Investment Support
Clinical decisions guided
Data-Driven
Product Strategy
Market opportunity validated
Our Perspectives on Advertising
2026 Oncology Market Access Trends
Implications of the IRA’s Maximum Fair Price (MFP) Negotiations
340B Drug Discount Program
Define Where Your Product Will Win
At BGBx, we build pharmaceutical product strategies that connect clinical innovation to market opportunity, ensuring every investment decision is grounded in evidence and insight.
